---
document_datetime: 2025-01-10 17:11:01
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/prehevbri-epar-all-authorised-presentations_en.pdf
document_name: prehevbri-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.8127421
conversion_datetime: 2025-12-21 17:17:27.557621
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| MA (EU) number   | (Invented) name   | Strength   | Pharmaceutical Form      | Route of Administration   | Immediate Packaging   | Content (concentration)   | Pack size   |
|------------------|-------------------|------------|--------------------------|---------------------------|-----------------------|---------------------------|-------------|
| EU/1/22/1641/001 | PreHevbri         | -- 1       | Suspension for injection | Intramuscular use         | vial (glass)          | 1 ml (10 µg/ml)           | 10 vials    |
| EU/1/22/1641/002 | PreHevbri         | -- 1       | Suspension for injection | Intramuscular use         | vial (glass)          | 1 ml (10 µg/ml)           | 1 vial      |

<!-- image -->